What Researchers Did
Researchers conducted a systematic review and meta-analysis to evaluate the influence of hyperbaric oxygen therapy (HBOT) on the survival of dental implants placed in patients who had received radiotherapy for head and neck cancer.
What They Found
After analyzing three eligible studies, the researchers found no evidence that hyperbaric oxygen therapy (HBOT) significantly changed the risk of dental implant failure in irradiated patients. Furthermore, the risk of an implant failing did not depend on its anatomical site.
What This Means for Canadian Patients
Canadian patients who have undergone head and neck radiotherapy and require dental implants may not benefit from hyperbaric oxygen therapy to improve implant survival. This suggests that HBOT might not be a necessary additional treatment in these specific clinical scenarios.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
A significant limitation is that the meta-analysis was based on only three eligible studies for statistical analysis.